Study Of Palbociclib In Combination With Letrozole As Treatment Of Postmenopausal Women With Hormone Receptor Positive, HER2-Negative Advanced Breast Cancer For Whom Letrozole Therapy Is Deemed Appropriate
Phase of Trial: Phase III
Latest Information Update: 24 Nov 2017
At a glance
- Drugs Letrozole (Primary) ; Palbociclib (Primary)
- Indications Advanced breast cancer
- Focus Adverse reactions; Registrational
- Sponsors Pfizer
- 20 Apr 2016 Status changed from not yet recruiting to recruiting.
- 04 Jan 2016 Planned End Date changed from 1 Nov 2018 to 1 Oct 2018, according to ClinicalTrials.gov record.
- 04 Jan 2016 Planned primary completion date changed from 1 Nov 2018 to 1 Oct 2018, according to ClinicalTrials.gov record.